Cardiology

No evidence of legacy effect seen for intensive glucose lowering

(HealthDay)—There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes, according to a study published in the June 6 issue of the New ...

Diabetes

Exercise, therapy may improve depression, diabetes outcomes

(HealthDay)—Exercise and/or behavioral treatment interventions may provide clinically meaningful improvements in depression outcomes in adults with type 2 diabetes (T2DM) and major depressive disorder (MDD), according to ...

Diseases, Conditions, Syndromes

T2DM is risk factor for liver fibrosis progression in NAFLD

Type 2 diabetes mellitus (T2DM) is a risk factor for progression of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), according to a study published online May 21 in the Journal of Gastroenterology ...

Diabetes

Poor glycemic control linked to sarcopenia in T2DM

(HealthDay)—For patients with type 2 diabetes, poor glycemic control is associated with sarcopenia, according to a study published online May 9 in the Journal of Diabetes Investigation.

Medications

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.

page 2 from 23